Poly[μ(2)-aqua-μ(2)-(pyrazine-2-carboxyl-ato)-lithium].

Acta crystallographica. Section E, Structure reports online 20120701

The chemotherapy of tuberculosis: past, present and future.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120601

catena-Poly[[[diaqua-nickel(II)]-μ-pyrazine-2-carboxyl-ato-silver(I)-μ-pyrazine-2-carboxyl-ato] nitrate dihydrate].

Acta crystallographica. Section E, Structure reports online 20120501

Disorder in the anionic part of catena-poly[[(pyrazine-2-carboxyl-ato)copper(II)]-μ-pyrazine-2-carboxyl-ato].

Acta crystallographica. Section E, Structure reports online 20120401

Investigation of in situ oxalate formation from 2,3-pyrazinedicarboxylate under hydrothermal conditions using nuclear magnetic resonance spectroscopy.

Inorganic chemistry 20120319

Structural motifs in phenylbismuth heterocyclic carboxylates--secondary interactions leading to oligomers.

Dalton transactions (Cambridge, England : 2003) 20120121

Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.

Tuberculosis (Edinburgh, Scotland) 20120101

Electrochemical and spectroscopic investigations of isoniazide and its analogs with ds.DNA at physiological pH: evaluation of biological activities.

European journal of medicinal chemistry 20120101

Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120101

Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.

PLoS pathogens 20120101

Synthesis and characterization of organic impurities in bortezomib anhydride produced by a convergent technology.

Scientia pharmaceutica 20120101

MSMEG_2731, an uncharacterized nucleic acid binding protein from Mycobacterium smegmatis, physically interacts with RPS1.

PloS one 20120101

Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.

The Yale journal of biology and medicine 20111201

catena-Poly[[(6-carb-oxy-pyrazine-2-carboxyl-ato)lithium]-μ-aqua].

Acta crystallographica. Section E, Structure reports online 20111201

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.

Science (New York, N.Y.) 20110916

Microbiology. Pyrazinamide--old TB drug finds new target.

Science (New York, N.Y.) 20110916

Cytotoxic and antimicrobial activities of Cu(II), Co(II), Pt(II) and Zn(II) Complexes with N,O-chelating heterocyclic carboxylates.

Archiv der Pharmazie 20110901

Tris(3-amino-pyrazine-2-carboxyl-ato-κN,O)diaqua-erbium(III) tetra-hydrate.

Acta crystallographica. Section E, Structure reports online 20110901

Poly[[(μ-3-amino-pyrazine-2-carboxyl-ato-κN,O:O')diaqua-(μ-oxalato-κO,O:O,O)lanthanum(III)] monohydrate].

Acta crystallographica. Section E, Structure reports online 20110901

8-Hy-droxy-2-methyl-quinolinium tetra-chlorido(pyrazine-2-carboxyl-ato-κN,O)stannate(IV) methanol monosolvate.

Acta crystallographica. Section E, Structure reports online 20110901

catena-Poly[[[bis-(3-amino-pyrazine-2-carboxyl-ato)triaqua-praseodymium(III)]-μ-3-amino-pyrazine-2-carboxyl-ato-[(3-amino-pyrazine-2-carboxyl-ato)diaqua-formatopraseodymium(III)]-μ-3-amino-pyrazine-2-carboxyl-ato] hexa-hydrate].

Acta crystallographica. Section E, Structure reports online 20110901

Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I.

Bioorganic & medicinal chemistry letters 20110815

catena-Poly[[(aqualithium)-μ-3-carboxypyrazine-2-carboxylato-κO,N:O,N] monohydrate].

Acta crystallographica. Section E, Structure reports online 20110801

Poly[[diaquadi-μ(2)-cyanido-bis-(μ(2)-pyrazine-2-carboxyl-ato)dicopper(I)copper(II)] dihydrate].

Acta crystallographica. Section E, Structure reports online 20110701

Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.

Biochimica et biophysica acta 20110601

Triethyl-ammonium tetra-chlorido(pyrazine-2-carboxyl-ato-κN,O)stannate(IV).

Acta crystallographica. Section E, Structure reports online 20110601

New three-dimensional metal-organic framework with heterometallic [Fe-Ag] building units: synthesis, crystal structure, and functional studies.

Inorganic chemistry 20110404

3-Meth-oxy-carbonyl-1-methyl-pyrazinium tetra-chlorido(pyrazine-2-carboxyl-ato-κN,O)stannate(IV).

Acta crystallographica. Section E, Structure reports online 20110201

Poly[[hepta-μ(2)-aqua-bis-(μ(2)-pyrazine-2-carboxyl-ato)dibarium] bis-(pyrazine-2-carboxyl-ate)].

Acta crystallographica. Section E, Structure reports online 20110201

Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs.

The Journal of antimicrobial chemotherapy 20110101

Antimicrobial Susceptibility Testing of Mycobacterium bovis Isolates from Michigan White-Tailed Deer during the 2009 Hunting Season.

Veterinary medicine international 20110101

Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.

PloS one 20110101

Poly[di-μ-aqua-μ(4)-(pyrazine-2,5-dicarboxyl-ato)-dilithium(I)].

Acta crystallographica. Section E, Structure reports online 20110101

Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.

Bioinformation 20110101

Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.

BMC infectious diseases 20110101

Antimycobacterial evaluation of pyrazinoic acid reversible derivatives.

Current pharmaceutical design 20110101

Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.

PloS one 20110101

Yersinia enterocolitica and Yersinia pseudotuberculosis Detection in Foods.

Journal of pathogens 20110101

Synthesis, structure and magnetic properties of two new azido-Co(II) coordination architectures: from ferromagnetic coupling to single-chain-magnets.

Dalton transactions (Cambridge, England : 2003) 20101214

Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.

Biochemistry 20101109

Reductive degradation of pyrazine-2-carboxylate by a newly isolated Stenotrophomonas sp. HCU1.

Biodegradation 20100901

Monoclinic modification of aquadi-n-butyl-bis-(pyrazine-2-carboxyl-ato-κN,O)tin(IV).

Acta crystallographica. Section E, Structure reports online 20100901

A series of transition metal-azido extended complexes with various anionic and neutral co-ligands: synthesis, structure and their distinct magnetic behavior.

Dalton transactions (Cambridge, England : 2003) 20100828

Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.

European journal of medicinal chemistry 20100801

catena-Poly[[[tetra-aqua-erbium(III)]-μ-oxalato-κO,O:O,O] [bromidobis(pyrazine-2-carboxyl-ato-κN,O)cuprate(II)] tetra-hydrate].

Acta crystallographica. Section E, Structure reports online 20100801

Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

Drug and chemical toxicology 20100701

The near future: improving the activity of rifamycins and pyrazinamide.

Tuberculosis (Edinburgh, Scotland) 20100501

Poly[aqua-(μ-pyrazine-2-carboxyl-ato-κN,O:O)(μ-pyrazine-2-carboxyl-ato-κN,O:O')lead(II)].

Acta crystallographica. Section E, Structure reports online 20100501

Photoluminescent lanthanide-organic bilayer networks with 2,3-pyrazinedicarboxylate and oxalate.

Inorganic chemistry 20100405

Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20100301

N'-[1-(4-Amino-phen-yl)ethyl]pyrazine-2-carbohydrazide.

Acta crystallographica. Section E, Structure reports online 20100301

QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.

Archiv der Pharmazie 20100201

Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human.

Biological & pharmaceutical bulletin 20100101

Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.

International journal of molecular sciences 20100101

Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.

BMC microbiology 20100101

Epidemiology of gout.

Arthritis research & therapy 20100101

Poly[hexa-aqua-bis(μ(3)-terephthalato)(μ(2)-terephthalato)diytterbium(III)].

Acta crystallographica. Section E, Structure reports online 20100101

Poly[bis-(μ(2)-pyrazine-2-carboxyl-ato)-κN,O:O';κN,O:O-cadmium(II)].

Acta crystallographica. Section E, Structure reports online 20100101

Ligand-based modification of the structures and optical properties of new silver(I)-rhenate(VII) oxide/organic hybrid solids.

Inorganic chemistry 20091207

A polymorph of diaqua-bis(pyrazine-2-carboxyl-ato-κN,O)copper(II).

Acta crystallographica. Section E, Structure reports online 20091201

Tetra-ethyl-ammonium tricarbonyl-chlorido-(pyrazine-2-carboxyl-ato-N,O)rhenate(I).

Acta crystallographica. Section E, Structure reports online 20091101

Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.

Molecules (Basel, Switzerland) 20091020

Combined Mössbauer spectral and density functional theory determination of the magnetic easy-axis in two high-spin iron(II) 2-pyrazinecarboxylate complexes.

Inorganic chemistry 20090907

Poly[diaqua-(μ(2)-oxalato-κO,O:O,O)(μ(2)-pyrazine-2-carboxyl-ato-κN,O:O,O')neodymium(III)].

Acta crystallographica. Section E, Structure reports online 20090901

Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production.

PLoS computational biology 20090801

Poly[[hemi-μ(4)-oxalato-hemi-μ(2)-oxalato-bis-(μ(3)-pyrazine-2-carboxyl-ato)erbium(III)silver(I)] monohydrate].

Acta crystallographica. Section E, Structure reports online 20090801

Derivatives of pyrazinecarboxylic acid: 1H, 13C and 15N NMR spectroscopic investigations.

Magnetic resonance in chemistry : MRC 20090701

Poly[[hemi-μ(4)-oxalato-hemi-μ(2)-oxalato-bis-(μ(3)-pyrazine-2-carboxyl-ato)neodymium(III)silver(I)] monohydrate].

Acta crystallographica. Section E, Structure reports online 20090701

Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090628

Poly[di-μ(2)-azido-μ(3)-pyrazine-2-carboxyl-ato-cadmium(II)].

Acta crystallographica. Section E, Structure reports online 20090501

Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.

The Journal of pharmacy and pharmacology 20090401

The identification of orally bioavailable thrombopoietin agonists.

Bioorganic & medicinal chemistry letters 20090301

3-(3-Amino-phenyl-sulfon-yl)aniline.

Acta crystallographica. Section E, Structure reports online 20090201

Genome-wide analysis of the PreA/PreB (QseB/QseC) regulon of Salmonella enterica serovar Typhimurium.

BMC microbiology 20090101

Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.

The Journal of international medical research 20090101

What lies behind serum urate concentration? Insights from genetic and genomic studies.

Genome medicine 20090101

Poly[diaqua-μ-oxalato-μ-pyrazine-2-carbox-yl-ato-lanthanum(III)].

Acta crystallographica. Section E, Structure reports online 20090101

Metal and mixed-metal coordination polymers synthesized with pyrazine-2-carboxylate.

Dalton transactions (Cambridge, England : 2003) 20081121

Vibrational spectroscopic studies and ab initio calculations of a substituted amide of pyrazine-2-carboxylic acid--C12H10ClN3O.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081115

Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.

The Journal of biological chemistry 20081003

Poly[diaqua(μ(2)-oxalato-κO,O:O,O)(μ(2)-pyrazine-2-carboxyl-ato-κN,O:O')cerium(III)].

Acta crystallographica. Section E, Structure reports online 20081001

Synthesis and structures of a new series of silver-vanadate hybrid solids and their optical and photocatalytic properties.

Inorganic chemistry 20080915

4-Carboxy-pyridazin-1-ium chloride.

Acta crystallographica. Section E, Structure reports online 20080801

Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13).

The Journal of biological chemistry 20080613

Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides.

European journal of medicinal chemistry 20080501

Mechanistic implications of the active species involved in the oxidation of hydrocarbons by iron complexes of pyrazine-2-carboxylic acid.

Dalton transactions (Cambridge, England : 2003) 20080421

Diaqua-bis(pyrazine-2-carboxyl-ato-κN,O)manganese(II) dihydrate.

Acta crystallographica. Section E, Structure reports online 20080401

Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase.

The FEBS journal 20080201

Interpretation of the multiple vanadium-oxygen bonds in the central VO(eta2-O2)+ group. Synthesis, structure, supramolecular interactions and DFT studies for complexes with 2,2'-bipyridine, 1,10-phenanthroline, pyrazinato(1-) and pyrazinamide ligands.

Dalton transactions (Cambridge, England : 2003) 20080107

Suppression of blood lipid concentrations by volatile Maillard reaction products.

Nutrition (Burbank, Los Angeles County, Calif.) 20080101

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals.

Nutrition & metabolism 20080101

Medical management of genitourinary tuberculosis.

Indian journal of urology : IJU : journal of the Urological Society of India 20080101

Dibromidobis(pyrazine-2-carboxylic acid-κN)mercury(II) dihydrate.

Acta crystallographica. Section E, Structure reports online 20080101

2'-(3-Hydroxy-benzyl-idene)pyrazine-2-carbohydrazide monohydrate.

Acta crystallographica. Section E, Structure reports online 20080101

Structural determination of hypnosin, a spore germination inhibitor of phytopathogenic Streptomyces sp. causing root tumor in melon (Cucumis sp.).

Journal of agricultural and food chemistry 20071226

Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors.

Molecules (Basel, Switzerland) 20071220

Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.

Drug metabolism and disposition: the biological fate of chemicals 20070901

Agonist lead identification for the high affinity niacin receptor GPR109a.

Bioorganic & medicinal chemistry letters 20070901

Oxidation of 2-propanol and cyclohexane by the reagent 'hydrogen peroxide-vanadate anion-pyrazine-2-carboxylic acid': kinetics and mechanism.

The journal of physical chemistry. A 20070816

Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series.

Bioorganic & medicinal chemistry letters 20070715

Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.

Antimicrobial agents and chemotherapy 20070701

Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.

Antimicrobial agents and chemotherapy 20070201

Human renal organic anion transporter 4 operates as an asymmetric urate transporter.

Journal of the American Society of Nephrology : JASN 20070201

Magnetic properties and molecular structures of binuclear (2-pyrazinecarboxylate)-bridged complexes containing Re(IV) and M(II) (M = Co, Ni).

Dalton transactions (Cambridge, England : 2003) 20070121

Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.

The Journal of pharmacology and experimental therapeutics 20070101

[Ln2(C2O4)2(pyzc)2(H2O)2]n[Ln = Pr (1), Er (2)]: novel two-dimensional lanthanide coordination polymers with 2-pyrazinecarboxylate and oxalate.

Inorganic chemistry 20061225

Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.

The Journal of antimicrobial chemotherapy 20061101

pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.

The Journal of antimicrobial chemotherapy 20061101

Polar symmetry and intercalation of new multilayered hybrid molybdates: [M2(pzc)2(H2O)x][Mo5O16] (M = Co, Ni).

Inorganic chemistry 20060612

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Renal urate transport.

Rheumatic diseases clinics of North America 20060501

Versatility in the binding of 2-pyrazinecarboxylate with iron. Synthesis, structure and magnetic properties of iron(II) and iron(III) complexes.

Dalton transactions (Cambridge, England : 2003) 20060407

Substituted pyrazinecarboxamides: synthesis and biological evaluation.

Molecules (Basel, Switzerland) 20060329

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

Structure (London, England : 1993) 20060301

The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.

The Journal of communicable diseases 20060301

Acid-base characterization of 5-hydroxypyrazine-2-carboxylic acid and the role of ionic equilibria in the optimization of some process conditions for its biocatalytic production.

Analytical and bioanalytical chemistry 20051001

A density functional theory study of the mechanism of free radical generation in the system vanadate/PCA/H2O2.

The journal of physical chemistry. B 20050929

Structural origin of chirality and properties of a remarkable helically pillared solid.

Inorganic chemistry 20050919

Phenolsulfonphthalein transport by potential-sensitive urate transport system.

European journal of pharmacology 20050822

Hydrothermal syntheses and structures of two mixed-valence copper(I,II) 2-pyrazinecarboxylate coordination polymers.

Inorganic chemistry 20050530

Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family.

The Biochemical journal 20050515

Synthesis and characterization of ReO4-containing microporous and open framework structures.

Inorganic chemistry 20040906

Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.

Journal of medical microbiology 20040801

Self-assembly of diorganotin(IV) moieties and 2-pyrazinecarboxylic acid: syntheses, characterizations and crystal structures of monomeric, polymeric or trinuclear macrocyclic compounds.

Dalton transactions (Cambridge, England : 2003) 20040621

Iron enhances the antituberculous activity of pyrazinamide.

The Journal of antimicrobial chemotherapy 20040201

Function and localization of urate transporter 1 in mouse kidney.

Journal of the American Society of Nephrology : JASN 20040201

A mixed matrix of 3-hydroxypicolinic acid and pyrazinecarboxylic acid for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of oligodeoxynucleotides.

Rapid communications in mass spectrometry : RCM 20040101

Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.

The Journal of antimicrobial chemotherapy 20031101

Urate transport via human PAH transporter hOAT1 and its gene structure.

Kidney international 20030101

The curious characteristics of pyrazinamide: a review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20030101

Augmentation of H2 photoproduction in Rhodopseudomonas palustris by N-heterocyclic aromatic compounds.

Biotechnology letters 20030101

Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.

Journal of medicinal chemistry 20021205

Functional analysis and molecular model of the human urate transporter/channel, hUAT.

American journal of physiology. Renal physiology 20020701

Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats.

Biopharmaceutics & drug disposition 20020701

Growth-promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of ACMSD activity.

Bioscience, biotechnology, and biochemistry 20020701

Escherichia coli genes involved in resistance to pyrazinoic acid, the active component of the tuberculosis drug pyrazinamide.

FEMS microbiology letters 20020604

Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.

Journal of bacteriology 20020401

Recurrence of carboxylic acid-pyridine supramolecular synthon in the crystal structures of some pyrazinecarboxylic acids.

The Journal of organic chemistry 20020125

Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.

Journal of medical microbiology 20020101

A new packing variant of catena-poly[[aquachlorocopper(II)]-mu-pyrazine-2-carboxylato-O,N:N'].

Acta crystallographica. Section C, Crystal structure communications 20011201

Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii.

Biochemistry 20011127

Anion-directed crystallization of coordination polymers: syntheses and characterization of Cu(4)(2-pzc)(4)(H(2)O)(8)(Mo(8)O(26)).2H(2)O and Cu(3)(2-pzc)(4)(H(2)O)(2)(V(10)O(28)H(4)).6.5H(2)O (2-pzc = 2-pyrazinecarboxylate).

Inorganic chemistry 20010312

Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.

Bioorganic & medicinal chemistry letters 20010122

pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.

BMC infectious diseases 20010101

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Respiratory research 20010101

Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.

Microbial drug resistance (Larchmont, N.Y.) 20000101

Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.

Journal of medicinal chemistry 19960816

Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity.

Journal of medicinal chemistry 19950929

Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.

Antimicrobial agents and chemotherapy 19950601

Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii.

Biochemical pharmacology 19940817

Antimycobacterial activity of a series of pyrazinoic acid esters.

Journal of medicinal chemistry 19920403

Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.

The Journal of infectious diseases 19900701

Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?

Antimicrobial agents and chemotherapy 19890801

Role of rifampicin in arthralgia induced by pyrazinamide.

Tubercle 19830601

Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

The American review of respiratory disease 19670301